Trade

Unjha Formulations share price

High risk
  • 48%Low risk
  • 48%Moderate risk
  • 48%Balanced risk
  • 48%High risk
  • 48%Extreme risk
  • ₹20.49(-1.01%)
    April 13, 2026 15:15:00 PM IST
    • NSE
    • BSE
  • Vol : 0.30 K (NSE + BSE)
    Last 20 day avg : 2.85 K

Unjha Formulations is trading -1.01% lower at Rs 20.49 as compared to its last closing price. Unjha Formulations has been trading in the price range of 20.70 & 20.49. Unjha Formulations has given -18.04% in this year & 1.24% in the last 5 days. Unjha Formulations has TTM P/E ratio 10.63 as compared to the sector P/E of 46.28.The company posted a net profit of 0.24 Crores in its last quarter.Listed peers of Unjha Formulations include Sun Pharmaceutical Industries (-0.16%), Divi's Laboratories (-1.01%), Torrent Pharmaceuticals (0.21%).The Mutual Fund holding in Unjha Formulations was at -% in . The MF holding has - from the last quarter. The FII holding in Unjha Formulations was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 14, 2026, 11:50 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -0.33
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.95
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    8.80
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
20.49
Highest
20.70
52 week range
Lowest
18.60
Highest
30.40
Unjha Formulations Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bearish
1,652.00-0.163,96,360.8035.835.70.960.50
Divi's Laboratories
Moderately Bearish
6,057.50-1.011,61,192.5272.0210.560.500.01
Torrent Pharmaceuticals
Bullish
4,166.000.211,41,432.3671.8918.260.8517.62
Lupin
Bullish
2,316.10-0.711,05,715.8131.356.090.5211.80
Dr Reddy's Laboratories
Bearish
1,235.000.241,03,092.0117.833.010.662.34
Unjha Formulations Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-04Quarterly Results
2025-11-10Quarterly Results
2025-08-06Quarterly Results
2025-05-16Audited Results
2025-03-17Others
About the company Unjha Formulations
  • IndustryBiotechnology & Drugs
  • ISININE576D01015
  • BSE Code531762
  • NSE Code
Unjha Formulations Limited is an India-based company, which is engaged in manufacturing and exporting of isabgol (psyllium) ayurvedic products. The Company is engaged in service to the isabgol (psyllium) ayurvedic formulation profession. It also manufactures all kinds of small volume ayurvedic isabgol (psyllium) powder and is tested at its plant with a modern and well equipped physico chemical and micro biological quality control laboratory. The Company’s Anchor Sat-Isabgol is available in 50 grams (gms), 100 gm, 200 gm, and 400 gm. Its isabgo husk formulation is available in the elaichi flavor. The Company’s Fibron is available in 100 gms and 300 gms. Its Isabgol Poder is available in the orange flavor. Its Fibron SF (sugar-free) is available in 100 gm and 300 gm.
  • Management Info
  • Jigar RayCompliance Officer, Company Secretary
  • Esha PatelExecutive Director
  • Krutiben PatelWhole time Director
Unjha Formulations Share Price FAQs

Unjha Formulations is trading at 20.49 as on Mon Apr 13 2026 09:45:00. This is -1.01% lower as compared to its previous closing price of 20.70.

The market capitalization of Unjha Formulations is 9.18 Cr as on Mon Apr 13 2026 09:45:00.

The 52 wk high for Unjha Formulations is 30.40 whereas the 52 wk low is 18.60

Unjha Formulations can be analyzed on the following key metrics -

  • TTM P/E: 10.63
  • Sector P/E: 46.28
  • Dividend Yield: 0.00%
  • D/E ratio: -

Unjha Formulations reported a net profit of 0.41 Cr in 2025.

Quick Links
EQUITY QUICK LINKS
Unjha Formulations QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Unjha Formulations share price